SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv

First Page		Document Content
Date: 2016-02-02 08:19:44 Anticoagulants Hematology Lactams Heparins Morpholines Rivaroxaban Venous thrombosis Thrombosis Low molecular weight heparin Direct Xa inhibitor Surgery Apixaban		SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv Add to Reading List Source URL: www.health.gov.nl.ca Download Document from Source Website File Size: 181,39 KB Share Document on Facebook

	A M E R I C A N S O C I E T Y O F DocID: 1qkK5 - View Document
	Monday October 10th, 2016 Amphitheatre xxx The success story of a carbohydrate” ENS Paris 29 rue d’Ulm ITMO Molecular and structural basis of life Paris 5ème DocID: 1ptev - View Document
	SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv DocID: 1p0MX - View Document
	April 21st, 2015 Kits for which Material Safety Data Sheets are not required The kits listed below are not labelled as hazardous. Considering the Regulation (EC) N° and the OSHA regulations 29 CFRg DocID: 1gtqX - View Document
	Guideline on non-clinical and clinical development of similar biological medicinal products containing low molecular-weight-heparins DocID: 1cDQr - View Document